Found: 10
Select item for more details and to access through your institution.
AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07070-1
- By:
- Publication type:
- Article
Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.680369
- By:
- Publication type:
- Article
Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.948042
- By:
- Publication type:
- Article
LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy.
- Published in:
- European Journal of Medical Research, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s40001-024-01690-1
- By:
- Publication type:
- Article
CHKB-AS1 enhances proliferation and resistance to NVP-BEZ235 of renal cancer cells via regulating the phosphorylation of MAP4 and PI3K/AKT/mTOR signaling.
- Published in:
- European Journal of Medical Research, 2023, v. 28, n. 1, p. 1, doi. 10.1186/s40001-023-01558-w
- By:
- Publication type:
- Article
Educational Practices and Algorithmic Framework for Promoting Sustainable Development in Education by Identifying Real-World Learning Paths.
- Published in:
- Sustainability (2071-1050), 2024, v. 16, n. 16, p. 6871, doi. 10.3390/su16166871
- By:
- Publication type:
- Article
Essential m<sup>6</sup>A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/9411692
- By:
- Publication type:
- Article
Development of a Novel KCNN4-Related ceRNA Network and Prognostic Model for Renal Clear Cell Carcinoma.
- Published in:
- Analytical Cellular Pathology: Cellular Oncology, 2023, v. 2023, p. 1, doi. 10.1155/2023/2533992
- By:
- Publication type:
- Article
Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2022, v. 29, p. 1, doi. 10.1177/10732748221129451
- By:
- Publication type:
- Article
Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article